Suppr超能文献

脑病:新兴的糖尿病并发症。

Encephalopathies: the emerging diabetic complications.

机构信息

Department of Pathology, Wayne State University, Detroit, MI 48201, USA.

出版信息

Acta Diabetol. 2010 Dec;47(4):279-93. doi: 10.1007/s00592-010-0218-0. Epub 2010 Aug 27.

Abstract

Diabetic encephalopathies are now accepted complications of diabetes. They appear to differ in type 1 and type 2 diabetes as to underlying mechanisms and the nature of resulting cognitive deficits. The increased incidence of Alzheimer's disease in type 2 diabetes is associated with insulin resistance, hyperinsulinemia and hyperglycemia, and commonly accompanying attributes such as hypercholesterolemia, hypertension and obesity. The relevance of these disorders as to the emergence of dementia and Alzheimer's disease is discussed based on epidemiological studies. The pathobiology of accumulation of β-amyloid and tau the hallmarks of Alzheimer's disease are discussed based on experimental data. Type 1 diabetic encephalopathy is likely to increase as a result of the global increase in the incidence of type 1 diabetes and its occurrence in increasingly younger patients. Alzheimer-like changes and dementia are not prominently increased in type 1 diabetes. Instead, the type 1 diabetic encephalopathy involves learning abilities, intelligence development and memory retrieval resulting in impaired school and professional performances. The major underlying component here appears to be insulin deficiency with downstream effects on the expression of neurotrophic factors, neurotransmitters, oxidative and apoptotic stressors resulting in defects in neuronal integrity, connectivity and loss commonly occurring in the still developing brain. Recent experimental data emphasize the role of impaired central insulin action and provide information as to potential therapies. Therefore, the underlying mechanisms resulting in diabetic encephalopathies are complex and appear to differ between the two types of diabetes. Major headway has been made in our understanding of their pathobiology; however, many questions remain to be clarified. In view of the increasing incidence of both type 1 and type 2 diabetes, intensified investigations are called for to expand our understanding of these complications and to find therapeutic means by which these disastrous consequences can be prevented and modified.

摘要

糖尿病性脑病现在被认为是糖尿病的并发症。它们在 1 型和 2 型糖尿病中的发病机制和认知缺陷类型似乎不同。2 型糖尿病中阿尔茨海默病的发病率增加与胰岛素抵抗、高胰岛素血症和高血糖有关,通常伴有高胆固醇血症、高血压和肥胖等常见伴随特征。根据流行病学研究,讨论了这些疾病与痴呆和阿尔茨海默病的发生的相关性。根据实验数据,讨论了β-淀粉样蛋白和 tau 积聚的病理生物学,这些是阿尔茨海默病的标志。1 型糖尿病性脑病可能会随着 1 型糖尿病发病率的全球增加和越来越年轻的患者发病而增加。1 型糖尿病中阿尔茨海默样变化和痴呆并没有明显增加。相反,1 型糖尿病性脑病涉及学习能力、智力发展和记忆检索,导致学习和职业表现受损。这里的主要潜在因素似乎是胰岛素缺乏,其对神经营养因子、神经递质、氧化和细胞凋亡应激物的表达产生下游影响,导致神经元完整性、连接性和常见于仍在发育中的大脑的丧失缺陷。最近的实验数据强调了中枢胰岛素作用受损的作用,并提供了关于潜在治疗方法的信息。因此,导致糖尿病性脑病的潜在机制很复杂,似乎在两种类型的糖尿病之间存在差异。我们对其病理生物学的理解已经取得了重大进展;然而,仍有许多问题需要澄清。鉴于 1 型和 2 型糖尿病的发病率不断增加,需要加强研究,以加深我们对这些并发症的理解,并找到治疗方法,以预防和改变这些灾难性后果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验